Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1949 1
1950 1
1951 1
1954 1
1955 1
1956 1
1957 1
1963 2
1964 1
1965 1
1966 1
1967 1
1977 2
1979 1
1980 1
1981 1
1982 5
1983 1
1986 2
1987 2
1989 4
1990 1
1991 3
1992 1
1993 1
1995 1
1996 3
1997 1
1998 1
1999 2
2000 4
2001 1
2002 4
2003 6
2004 5
2005 5
2006 6
2007 9
2008 2
2009 1
2010 8
2011 7
2012 8
2013 8
2014 6
2015 1
2016 6
2017 7
2018 5
2019 3
2020 7
2021 2
2022 2
2023 3
2024 2
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "1-methylpyridin-2-one"
Page 1
Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.
Irie J, Inagaki E, Fujita M, Nakaya H, Mitsuishi M, Yamaguchi S, Yamashita K, Shigaki S, Ono T, Yukioka H, Okano H, Nabeshima YI, Imai SI, Yasui M, Tsubota K, Itoh H. Irie J, et al. Endocr J. 2020 Feb 28;67(2):153-160. doi: 10.1507/endocrj.EJ19-0313. Epub 2019 Nov 2. Endocr J. 2020. PMID: 31685720 Free article. Clinical Trial.
Results of ophthalmic examination and sleep quality score showed no differences before and after the intervention. Plasma concentrations of N-methyl-2-pyridone-5-carboxamide and N-methyl-4-pyridone-5-carboxamide were significantly increased dose-depend …
Results of ophthalmic examination and sleep quality score showed no differences before and after the intervention. Plasma concentrations of …
N'-METHYL-2-PYRIDONE-5-CARBOXAMIDE INHUMAN PLASMA.
ABELSON D, BOYLE A, DEPATIE C, SELIGSON H. ABELSON D, et al. Clin Chim Acta. 1963 Jul;8:603-6. doi: 10.1016/0009-8981(63)90111-6. Clin Chim Acta. 1963. PMID: 14063976 No abstract available.
N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin.
Lenglet A, Liabeuf S, Bodeau S, Louvet L, Mary A, Boullier A, Lemaire-Hurtel AS, Jonet A, Sonnet P, Kamel S, Massy ZA. Lenglet A, et al. Toxins (Basel). 2016 Nov 15;8(11):339. doi: 10.3390/toxins8110339. Toxins (Basel). 2016. PMID: 27854278 Free PMC article. Review.
N-methyl-2-pyridone-5-carboxamide (2PY, a major metabolite of nicotinamide, NAM) was recently identified as a uremic toxin. ...
N-methyl-2-pyridone-5-carboxamide (2PY, a major metabolite of nicotinamide, NAM) was recently identified as a ur …
N-methyl-2-pyridone-5-carboxamide: a novel uremic toxin?
Rutkowski B, Slominska E, Szolkiewicz M, Smolenski RT, Striley C, Rutkowski P, Swierczynski J. Rutkowski B, et al. Kidney Int Suppl. 2003 May;(84):S19-21. doi: 10.1046/j.1523-1755.63.s84.36.x. Kidney Int Suppl. 2003. PMID: 12694300 Free article. Review.
BACKGROUND: N-methyl-2-pyridone-5-carboxamide (2PY) is one of the end products of nicotinamide-adenine dinucleotide (NAD) degradation. ...
BACKGROUND: N-methyl-2-pyridone-5-carboxamide (2PY) is one of the end products of nicotinamide-adenine dinucleot …
Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure.
Slominska EM, Smolenski RT, Szolkiewicz M, Leaver N, Rutkowski B, Simmonds HA, Swierczynski J. Slominska EM, et al. Mol Cell Biochem. 2002 Feb;231(1-2):83-8. doi: 10.1023/a:1014445329756. Mol Cell Biochem. 2002. PMID: 11952169
Intracellular catabolism of NAD in mammalian cells occurs mainly via reaction catalyzed by poly(ADP-ribose) polymerase (PARP) with the release of nicotinamide, which is then metabolized predominantly to N-methyl-2-pyridone-5-carboxamide (2PY). PARP cou …
Intracellular catabolism of NAD in mammalian cells occurs mainly via reaction catalyzed by poly(ADP-ribose) polymerase (PARP) with the relea …
Nicotinamide and insulin sensitivity.
Paul TL, Hramiak IM, Mahon JL, Freeman D, Atkison P, Finegood DT, Dupre J. Paul TL, et al. Diabetologia. 1993 Apr;36(4):369. doi: 10.1007/BF00400244. Diabetologia. 1993. PMID: 8477885 No abstract available.
153 results